Search
Displaying 71–80 of 853 results for “vision connection”
-
Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial
Research NewsThe company plans to administer a higher dose of the emerging gene therapy to the next group of patients.
-
Research News
Most participants with advanced retinitis pigmentosa (RP) in the trial had improved navigation and/or object discrimination in reduced lighting conditions
-
The Foundation Fighting Blindness is inviting you to share your vision-loss journey through written word, audio or video as a part of our October “Share Your Vision” campaign. Help your friends, family, and even people you don’t know, see the world through your eyes—because your story is powerful and unique.
-
Kiora to Launch Clinical Trial in Australia for Vision-Restoring Small Molecule for RP Patients
Research NewsThe approach bestows light sensitivity to retinal ganglion cells for people who have lost their photoreceptors
-
Drug for Alcohol Abuse May Restore Vision for People with Retinal Diseases
Research NewsThe drug holds promise for enabling retinal-disease patients to get more vision from remaining photoreceptors
-
Learning to Fall After Vision Loss
Beacon StoriesWhen Justin’s vision loss progressed quickly due to retinitis pigmentosa at 25 years old, he thought skateboarding wouldn’t be possible anymore. Ten years later, with the help of his white cane and audio devices, Justin is now working to enhance accessibility in skateboarding for the blind and visually impaired community.
-
Virtual VISIONS 2020 Recorded Sessions
Recorded presentations from Virtual Visions 2020.
-
Foundation and Vision Partners Seek Biomedical Research Support from Congress during COVID-19 Crisis
Foundation NewsDelays in Research Impacting Therapy Development
-
Vision and Eye Health Awareness Calendar
Many different blindness-related awareness campaigns occur throughout the year. Not all of them are coordinated by the Foundation Fighting Blindness; however, we do support efforts to create a greater awareness of blindness.
-
History Is Made: FDA Approves Spark's Vision-Restoring Gene Therapy
Research NewsKnown as LUXTURNA™ (voretigene neparvovec), the gene therapy restored vision in a clinical trial for people between the ages of 4 and 44 with Leber congenital amaurosis (LCA) caused by mutations in the gene RPE65.
.jpg)
